Context: Type 2 diabetes and cardiovascular disease occur more frequently and at a younger age in South-Asians than Europeans. This may be related to differences in regulation of the fatty acid metabolism during aging. We compared age-related acylcarnitine and amino acid concentrations in Dutch and South-Asian Surinamese study participants.
T ype 2 diabetes (T2D) and cardiovascular disease (CVD) occur more frequently in populations of South-Asian than European origin. The incidence of these diseases increases with age (1, 2), but age of onset often is younger in those of South-Asian origin (3, 4) . The causes of these differences are not fully understood.
Recently, increased plasma levels of long-chain fatty acid (LCFA) and amino acid metabolism, including acylcarnitines and branched-chain amino acids (BCAAs), have been associated with T2D and CVD (5-7). During aging, LCFA homeostasis is dysregulated, ultimately leading to ectopic fat accumulation, increased use of nonoxidative pathways such as ceramide biosynthesis, and lipoapoptosis (8) . Impaired BCAA catabolism is reflected by higher levels of BCAAs (i.e., leucine, isoleucine and valine) and the accumulation of acylcarnitines derived from the intermediates of BCAA metabolism (9) . Different long-chain acylcarnitines, intermediates of LCFA catabolism, have been shown to accumulate in T2D and CVD (6, 7) indicating impaired fatty acid oxidation. It has been suggested recently that diminished BCAA catabolism impairs the use of fatty acid oxidation products (acetyl-coenzyme A) by causing "anaplerotic stress" due to reduced levels of BCAA-derived tricarboxylic cycle intermediates (9) .
To study the differences in etiology of diseases related to LCFA and amino acid metabolism, differences in related metabolite levels between South-Asian Surinamese and the Dutch were studied, as were changes in metabolite levels over age periods. We hypothesized that LCFA and amino acid metabolism, as reflected in plasma concentrations of acylcarnitines and amino acids, is either dysregulated from a younger age in South-Asians than in Europeans or increases more rapidly with age. A study by Tillin et al. (10) found that serum concentrations of the amino acids isoleucine, phenylalanine, tyrosine, and alanine were higher in South-Asian men than among European men. In addition, a small study found differences in amino acid and acylcarnitine levels between middle-aged men and women of South-Asian and European descent (11) . In our cross-sectional study, we addressed the following two questions: How do acylcarnitines and amino acids differ by age in Dutch and South-Asian Surinamese men and women 18 to 70 years old living in Amsterdam, Netherlands? Do age trends in acylcarnitine and amino acid levels differ between these ethnic groups?
Methods

Population
We used baseline data of the Healthy Life in an Urban Setting (HELIUS) study, collected between 2011 and 2015. HELIUS is a multiethnic cohort study among six ethnic groups living in Amsterdam. A detailed description of the design was previously published (12, 13) . In brief, participants were randomly sampled from the municipal register, stratified by ethnicity. Questionnaires, physical examinations, and biological samples were obtained. Full data were collected among 22,165 participants, from whom we selected those of Dutch and SouthAsian Surinamese ethnicity (n = 7607). We then excluded participants who did not provide permission for data linkage or storage of biological material (n = 671), and those who had fewer than two vials of EDTA-plasma available in the biobank (n = 186). In addition, participants with T2D, based on selfreport, increased fasting glucose level ($7.0 mmol/L), increased HbA1c ($48 mmol/mol), or use of glucose-lowering medication were excluded (n = 773) because the current study is part of a HELIUS substudy aimed at studying causes of incident T2D. From the 5977 participants (n = 3972 of Dutch origin and n = 2005 of South-Asian Surinamese origin) who remained in the study, we took a random sample of 350 participants per ethnic group in whom metabolite concentrations were determined using the sample function in the R statistical software package. HELIUS was approved by the Institutional Review Board of the Amsterdam Medical Center (MREC 10/100# 17.10.1729). All participants provided written informed consent.
Measurements
Ethnicity was defined by the individual's country of birth combined with the parental countries of birth. Dutch ethnicity was assigned to participants born in the Netherlands whose parents were born in the Netherlands. South-Asian Surinamese ethnicity was assigned to participants born in Suriname with at least one parent born in Suriname (first generation) or born in the Netherlands with both parents born in Suriname (second generation) combined with self-reported South-Asian ethnic origin.
The total reported fat intake and total energy intake were derived from an ethnic-specific food frequency questionnaire, which was answered by a subsample of the HELIUS cohort, as described in detail elsewhere (14) . The food frequency questionnaire data were available for 259 participants in our study sample, of whom 58 were Dutch men, 47 were South-Asian men, 67 were Dutch women, and 87 were South-Asian women.
Laboratory methods
Blood was collected after a fasting period of at least 10 hours. Concentrations of acylcarnitines and free carnitine were determined in plasma by tandem mass spectrometry, as described previously (15) . Amino acid concentrations were determined in plasma by tandem mass spectrometry, as previously described (16) .
Statistical analyses
We first examined the distributions of the metabolite data. Metabolites with .5% of the data below the detection limit were excluded from further analyses, because imputation may lead to inaccuracies (acylcarnitines: C5:1, C5OH, C4DC,  C53M3OH, C8DC, C14OH, C16:1OH, C16OH, C18:2OH,  C18: 1OH, and C18OH) (17) . We described the ethnic differences in these excluded metabolites by a description of the percentage of data below the detection limit per ethnic group and an overview of the median concentration of the values measured above the detection limit. For the included metabolites, we imputed half the detection limit for any measurements below the detection limit. Finally, outliers for glycine (n = 1), serine (n = 1), and asparagine (n = 1) were regarded as missing. Then we inspected the normal distribution of variables by plotting histograms and checking skewness and kurtosis. Many metabolites were not normally distributed; therefore, the acylcarnitines and amino acids were 10log transformed before further analysis.
Second, we made a summary score of the metabolites, conducting a principal component analysis (PCA). PCA was used because the included metabolites are highly correlated, and PCA is then able to reduce the dimensionality of the data set. We first checked the sampling adequacy by the Kaiser-Meyer-Olkin measure. Furthermore, we checked whether the correlation between metabolites was sufficiently large with the Bartlett test of sphericity. The PCA was conducted on the log-transformed metabolites with orthogonal rotation. Data were zero centered and scaled before analysis. The extracted principal components (PCs) were characterized as the main outcome, whereas individual metabolites were evaluated in secondary analyses. Therefore, we only corrected the analyses of individual metabolites for multiple testing using the Holm method (18) . Glutamate and glutamine can be converted into each other in the samples, as can asparagine and aspartate. Therefore, we additionally examined these metabolites combined. It has been suggested that levels of unsaturated acylcarnitines may be higher in South-Asian Surinamese than in the Dutch (11) . Therefore, we also explored the C10:1/C10 carnitine ratio because this ratio adequately reflects the relative presence of unsaturated and saturated fatty acids.
Third, we examined baseline characteristics and metabolite concentrations among men and women in each ethnic group. We calculated means and SD for continuous normally distributed variables, medians and interquartile ranges for continuous nonnormally distributed variables, and numbers of observations and percentages for categorical variables. Ethnic differences in the means of normally distributed variables were analyzed by a t test; ethnic differences in the medians of nonnormally distributed variables were analyzed by Kolmogorov-Smirnov tests. The x 2 test was used to check for ethnic differences in categorical variables. In addition, ethnic differences in metabolite concentrations adjusted for age and for age and body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) were studied by linear regression.
Then we analyzed the association of metabolites with age. Yu et al. (19) reported the association to be linear; we verified this visually in our population by plotting scatterplots in the total population and stratified by sex. We analyzed the association of age with metabolites by linear regression, in which the metabolite concentration was extrapolated to age 0 years and was set to 100%. In addition, the interaction of age with sex was checked because of indications of sexual dimorphism in the metabolome (20) . This was done by adding an interaction term between age and sex. We found an interaction between age and sex; therefore, we stratified for sex in all analyses. We then adjusted for BMI in our models because Yu et al. (19) indicated BMI was significantly correlated with both age and metabolite concentrations. Because BMI may reflect different levels of intra-abdominal fat storage in European than in SouthAsian populations, we checked whether results for PC1 and PC2 were robust when additionally adjusted for waist-to-hip ratio (WHR). Subsequently, we checked whether the association between metabolites and age differed by ethnic group by adding an interaction term between age and ethnicity in our models.
Finally, metabolite levels may be influenced by the amount of substrate available. Therefore, we checked whether the results were consistent when adjusted for fat and energy intake. This was done in a subgroup for whom a food frequency questionnaire (n = 259) was available. All analyses were conducted in RStudio, version 0.99.903 (https://www.rstudio. com) (21) .
Results
Baseline characteristics
The mean age among Dutch men (46.6 years; SD, 13.4) was higher than among South-Asian Surinamese men (43.1 years; SD, 12.7), whereas women of both ethnic groups were of similar age (Supplemental Table 1 ). Mean BMI was lower among Dutch women than among South-Asian Surinamese women, but did not differ among men. Fat and energy intake, available for a subset of the population, was lower among South-Asian Surinamese than among Dutch in both men and women.
PCA
The Kaiser-Meyer-Olkin measure of sampling adequacy was 0.90, with all scores above 0.50 (range, 0.53 to 0.98). Moreover, the Bartlett test of sphericity showed the correlation between metabolites was sufficiently large to perform a PCA [x 2 946 = 24,084; P , 0.001]. The scree plot (Supplemental Fig. 1) showed an inflection at the third PC; therefore, the first two components were retained. These could explain 40.1% of the variance in the data. Table 1 shows the factor loadings after rotation. The items that cluster on the same components suggest PC1 represents the metabolites reflective of the acylcarnitine metabolism; PC2 represents the metabolites reflective of the amino acid metabolism.
Baseline metabolite concentrations
Some ethnic differences in metabolite concentrations were observed. PC1 (acylcarnitine) indicated that metabolite concentrations were higher among South-Asian Surinamese men than among Dutch men (Table 2) , whereas PC2 (amino acids) indicated higher metabolite concentrations in South-Asian Surinamese men and women than in Dutch men and women. Similar results were found for the age-adjusted analyses (data not shown) and the age-and BMI-adjusted analyses (Supplemental Table 2 ). Similarly, ethnic differences in individual metabolite concentrations were observed (Table 2) , although the direction of the differences varied. Free carnitine concentrations were higher among South-Asian Surinamese participants than Dutch participants. Moreover, some medium-and long-chain acylcarnitine concentrations, in particular C10:1, C14:2, and C18:2, were higher among South-Asian Surinamese than among Dutch men and women, and others (e.g., C16:1, C18:1, and C18 in men) were significantly lower in South-Asian Surinamese than in Dutch participants. This is also illustrated by the significantly elevated C10:1/C10:0 ratio in South-Asian Surinamese participants. For individual amino acids, larger ethnic differences were observed among men than among women (Table 3) , but the directionality of the results was similar in both sexes. Most amino acid concentrations were higher among South-Asian Surinamese than among Dutch, but glycine and glutamine (in men) concentrations were lower.
Ethnic differences in metabolite concentrations remained similar after age adjustment (data not shown) or age and BMI adjustment (Supplemental Table 3 ), although there were some shifts in significance levels. Finally, there were no major ethnic differences in baseline concentrations of the excluded metabolites (Supplemental Table 4 ).
Metabolite patterns by age
No differences in age trends for metabolites were observed by ethnicity in either men or women (Tables 3 and  4) . PC1, reflective of the acylcarnitine metabolism, decreased by age in all groups (Fig. 1) . The negative factor loadings of this PC imply an increase in acylcarnitine levels with age. This was also reflected in the individual acylcarnitine concentrations, particularly in women. In women, age trends in most acylcarnitine concentrations were observed, especially in those reflected in PC1. For instance, C16:1-carnitine increased with age (per 10-year increment in age in Dutch women: 113.3%; 95% CI, 107.7, 119.1). Similar results were observed for SouthAsian women (111.0%; 95% CI, 106.2, 116.1).
Age patterns for PC2 were less clear (Fig. 1) . No age trend was observed in men, whereas in women, PC2 increased (statistically significant in South-Asian Surinamese women, P 5 0.01). Similarly, only citrulline and glutamine levels increased with age in men, whereas citrulline, glutamine, phenylalanine, tyrosine, glycine, ornithine,and arginine concentrations increased in women. Levels of asparagine, with a relatively low loading on PC2, decreased with age in women.
Sensitivity analyses
All analyses were repeated while adjusted for fat intake and adjusted for energy intake in a subgroup of participants who had food frequency questionnaire data available (data not shown). The ethnic differences in PC1, PC2, and the acylcarnitine levels remained largely similar to the main results, as did the age trends. However, many acylcarnitine levels were no longer statistically significantly different between ethnic groups. Moreover, the magnitude of the changes in metabolite concentrations by age decreased. For instance, the C18:0-carnitine concentration was 112.9% (95% CI, 108.5, 117.4) for a 10-year increase in age compared with the baseline value in Dutch women in the unadjusted analysis; for fatadjusted analysis, it was 101.1% (95% CI, 100.5, 101.7). Nevertheless, the directionality of the results was similar to that of the main results. Additional adjustment of PC1 and PC2 for WHR did not alter the results (data not shown).
Discussion
Our study suggests that concentrations of some acylcarnitines and amino acids, reflective of a dysfunctional LCFA metabolism, are higher among South-Asian Surinamese men than Dutch men. In women, amino acid concentrations were higher among South-Asian than Dutch participants. Most metabolite concentrations increase with age, especially in women, and trends are similar in South-Asian Surinamese and Dutch participants. Together, this suggests that metabolic profiles differ between both ethnic groups at any age in adulthood, but the progression of dysregulation of LCFA metabolism with aging is similar in both ethnic groups.
Ethnic differences
Mean amino acid levels were higher among SouthAsian Surinamese than Dutch populations, confirming results reported by Tillin et al. (10) that showed aromatic amino acid concentrations to be higher among SouthAsian men than European men living in the United Kingdom, and expanding the evidence to women. Similar ethnic differences in amino acid concentrations were also reported in a small study by van Valkengoed et al. (11) studies, the BCAA levels (i.e., leucine, isoleucine and valine) were higher in South-Asian Surinamese than Dutch participants in our study. In addition, it is worth noting that the pattern of the elevated amino acids in South-Asian Surinamese (specifically, elevations of methionine, alanine, phenylalanine, tyrosine, and lysine) corresponds to that seen in persons with reduced liver function (22) Analyses were adjusted for BMI.
Abbreviation: SA Sur, South-Asian Surinamese. a P values are given for the age coefficient in the linear regression. P values for the individual metabolites were adjusted on the basis of the Holm method; P values , 0.05 were considered statistically significant and are marked in bold. b A ↑ before P values indicates metabolite levels that significantly increased by age; ↓ indicates metabolite levels that significantly decreased by age.
among South-Asian Surinamese than among Dutch were reported. Our study showed similar trends; for instance, C18:0-carnitine concentrations were lower among South-Asian Surinamese than Dutch participants, whereas C18:2-carnitine concentrations were higher. Also, the C10:1/C10:0 ratio, which represents the relative abundance of unsaturated vs saturated fatty acids, was clearly higher in South-Asian Surinamese participants. This is likely partially reflective of ethnic differences in dietary intake, and is consistent with the observation that South-Asian Surinamese consume more (poly)unsaturated fatty acids than do the Dutch (23). Our analyses were adjusted for BMI because the study by Yu et al. (19) indicated metabolites to be correlated with both age and BMI. The correlation between BMI and metabolites may be due to storage of fat in the body. However, BMI does not reflect storage of intra-abdominal fat content similarly in Europeans and South-Asians (24) . To account for ethnic differences in distribution of body-fat storage, we adjusted for WHR in sensitivity analyses; however, this did not alter our results. Therefore, we do not expect differences in intra-abdominal fat storage to have affected our results, but future studies may measure fat content directly or use biomarkers such as adiponectin for confirmation.
Age-related differences
Acylcarnitine concentrations originating from fatty acid degradation increased with age, especially in women.
Not many studies are available that investigated age trends in acylcarnitines in adult populations. Consistent with our study, Yu et al. (19) showed a clear linear increase in most acylcarnitine concentrations with age in populations from Germany and the United Kingdom. They also reported on amino acids and in accordance with that study, we also found large sex differences and age trends in amino acid levels, which were most prominent among women. Our study suggested a nonsignificant reduction in tryptophan by age, as did the study by Yu et al. (19) . In addition, the study by Yu et al. (19) suggested a reduction in histidine, which was not measured in our study.
Our results for amino acids were partly consistent with a study by Kouchiwa et al. (25) , who showed increases and decreases in amino acid concentrations with age in a Japanese population. Most of our results were consistent with this study, although not all findings were statistically significantly replicated (25) . Some amino acids (e.g., serine) did not show clear consistent age trends. The small differences in metabolite concentrations between both studies may be related to dietary intake, which differs between ethnic groups and by age (26, 27) . To study the effect of dietary intake on differences in metabolite concentrations, analyses were additionally adjusted for dietary intake in sensitivity analyses in a subset of the population. This did not affect our results and, thus, we assume that dietary intake has limited effect on our findings. The study of Kouchiwa et al. (25) , however, did not adjust for dietary intake and, therefore, may not be completely comparable to ours. The study was conducted in Japan, where dietary changes by age may be different from those in the Netherlands and, therefore, may have affected metabolite trends differently by age.
The increase of LCFA with age may indicate a progressively dysregulated metabolism. This may reflect decreasing renal function. However, additional adjustment for renal function did not alter our results (data not shown).
The dysregulation of LCFA metabolism may be associated with the increase in incidence of chronic diseases such as T2D and CVD with age; previous studies indicated associations between acylcarnitines and amino acids with T2D and CVD (5-7, 10). We cannot exclude, however, reversed causality, and prediabetes and CVD may cause disturbances in LCFA metabolism as well. Furthermore, risk factors such as dietary intake may influence both metabolite levels as well as the risk for T2D and CVD. In this study, we show that the observed age trends in acylcarnitine and amino acid concentrations are similar in South-Asian Surinamese and Dutch populations. However, mean metabolite concentrations are higher in South-Asians than in Dutch already at the start of adulthood. Because these higher metabolite levels are associated with T2D and CVD, our findings are consistent with the observation that South-Asians develop T2D and CVD at a younger age than do the Dutch (3, 4) . The age of participants in our study population was limited to adults age 18 to 70 years; thus, our results cannot be extrapolated to younger age groups. Studies are needed to investigate whether ethnic differences in metabolite concentrations exist from birth or develop during childhood (28) . If it is elucidated how and when during the life course differences in metabolite concentrations arise, this may help identify how to prevent disturbance of LCFA metabolism. Differences in metabolite concentrations may also be used to identify those at high risk of developing T2D and CVD. Currently, there is a lack of quality biomarkers that can distinguish those at higher risk for T2D and CVD. But if markers are identified, this may help to target high-risk populations. Furthermore, this will possibly help develop preventive strategies aimed at delaying or preventing metabolic disturbances.
Limitations
Our study is not exempt of limitations. First, the results may be affected by selective participation or inclusion of participants. Although participants within HELIUS were randomly selected from the general population, recruitment rates into the study were low (28%). However, comparisons of responders and nonresponders suggest that participants represent the general population (13). When we further compared HELIUS participants who consented to data linkage and stored physical material with those who did not, no clear differences were observed (data not shown). Therefore, we assume that our included population represents the general population. However, we limited our analyses to participants who were not diagnosed with T2D at baseline. This may potentially have excluded participants with most dysregulated LCFA metabolism, reflected in serum metabolite levels, and may also explain differences in metabolite concentrations with previous studies. Because the prevalence of T2D is higher among South-Asian Surinamese participants than among Dutch participants (29), differences in metabolite profiles between both ethnic groups may be larger in the overall population.
Second, we used a cross-sectional study design; therefore, our results may reflect cohort effects, and characteristics of older participants may be different from those of younger ones. Although this effect is not likely because of the observed linear relationship between age and metabolites, longitudinal studies are required to document age-related effects.
Finally, the measured metabolite concentrations may have been insufficient to adequately characterize differences between the ethnic groups. Metabolite levels may fluctuate. Our analysis, therefore, could have benefitted from multiple measurements. In addition, although plasma metabolite concentrations measured in this study reflect the dysregulation of LCFA metabolism, the measured levels may not necessarily reflect the role of the processes in all individual organ compartments and its interplay in the body (30) . Metabolite concentrations measured in specific target organs, therefore, may yield different results.
We studied the differences in plasma metabolites related to LCFA metabolism between South-Asians and Europeans and their development with age. We found that many metabolite concentrations reflective of a dysregulated LFCA metabolism are higher among SouthAsian Surinamese than among Dutch participants. With aging, metabolite concentrations increased at a similar rate in both ethnic groups, indicating that differences in LCFA metabolism between South-Asian Surinamese and Dutch exist already at the start of adulthood. It remains to be established whether the observed differences in LCFA metabolism potentially mark or explain the earlier onset of T2D and CVD among South-Asian Surinamese.
